Local Bounti Corporation/DE
LOCL NYSE Agricultural Production-Crops Financials FY2020βFY2025
What Local Bounti Corporation/DE does
No business description yet.
- Legal name
- Local Bounti Corporation/DE
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 27, 2026
- Accession Β· CIK
- 0001628280-26-021706
0001840780
Revenue and margins
Local Bounti Corporation/DE had $48.4M of revenue in fiscal 2025, up 26.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$41.9M in fiscal 2025, β86.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Local Bounti Corporation/DE returned β to shareholders in fiscal 2025. The diluted share count rose 99.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Local Bounti Corporation/DE can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $96.7M | $13.7M | $10.3M | $0.9M | $4.2M |
| Debt incl. finance leases | $11.2M | $120M | $278M | $457M | $483M |
| Debt / equity | 0.1x | 1.0x | 18.2x | β | β |
| Current ratio | 5.9x | 1.5x | 0.8x | 0.3x | 1.4x |
| Quick ratio | 5.8x | 1.3x | 0.7x | 0.2x | 0.9x |
| Total assets | $144M | $279M | $382M | $428M | $410M |
| Total liabilities | $42.2M | $157M | $366M | $529M | $577M |
| Shareholders' equity | $102M | $121M | $15.3M | β$101M | β$166M |
| Net debt (β = net cash) | β$85.5M | $106M | $268M | $456M | $479M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 3 / 9 | 3 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | β50.2% | β47.0% | β29.5% | β27.5% | β22.9% | β15.3% |
| Altman Z'' | β11.67 | 2.88 | β3.31 | β4.69 | β4.91 | β5.35 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $0.1M | $0.6M | $19.5M | $27.6M | $38.1M | $48.4M |
| Net interest income | β$0.5M | β$6.6M | β$16.7M | β$25.7M | β | β |
| Provision for credit losses | $0.0M | $0.0M | $0.1M | $0.0M | β$0.1M | $0.0M |
| Gross profit | β$0.0M | $0.2M | $2.2M | $2.2M | $4.1M | $5.9M |
| Research and development | $1.1M | $3.4M | $14.1M | $16.1M | $22.3M | $25.6M |
| Operating income | β$7.9M | β$44.7M | β$94.5M | β$117M | β$59.0M | β$62.6M |
| Pretax income | β$8.4M | β$56.1M | β | β | β | β |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$8.4M | β$56.1M | β$111M | β$124M | β$120M | β$94.4M |
| Net income to common | β | β | β | β | β$120M | β$94.8M |
| Diluted EPS | β$0.17 | β$1.06 | β$16.57 | β$15.61 | β$14.14 | β$5.61 |
| Diluted shares | 0.05B | 0.05B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||
| Cash from operations | β$3.8M | β$20.1M | β$48.8M | β$33.2M | β$27.1M | β$30.3M |
| Capital expenditure | $3.4M | $29.7M | $56.0M | $162M | $82.5M | $11.6M |
| Free cash flow | β$7.3M | β$49.8M | β$105M | β$195M | β$110M | β$41.9M |
| Depreciation and amortization | $0.3M | $0.7M | $10.4M | $13.1M | $18.9M | $23.2M |
| Stock-based compensation | $3.3M | $17.9M | $39.2M | $16.3M | $3.3M | $5.2M |
| Acquisitions | β | $0.0M | $90.6M | $0.0M | β | β |
| Balance sheet | ||||||
| Cash and short-term investments | $0.0M | $96.7M | $13.7M | $10.3M | $0.9M | $4.2M |
| Total debt | $0.2M | $11.2M | $120M | $278M | $457M | $483M |
| Finance lease liabilities | β | β | β | β | $0.3M | $0.2M |
| Current assets | $0.6M | $106M | $34.1M | $27.0M | $18.8M | $22.0M |
| Current liabilities | $2.4M | $18.0M | $23.3M | $31.9M | $55.4M | $16.3M |
| Inventory | $0.2M | $0.9M | $3.6M | $4.2M | $6.8M | $7.4M |
| Property and equipment, net | β | $37.4M | β | $313M | $371M | $357M |
| Goodwill | β | $0.0M | $38.5M | $0.0M | β | β |
| Intangible assets | β | $0.0M | $47.3M | $41.4M | $37.8M | $30.8M |
| Total assets | $9.1M | $144M | $279M | $382M | $428M | $410M |
| Total liabilities | $11.7M | $42.2M | $157M | $366M | $529M | $577M |
| Shareholders' equity | β$2.6M | $102M | $121M | $15.3M | β$101M | β$166M |
| Margins | ||||||
| Gross margin | β11.0% | 32.3% | 11.4% | 8.0% | 10.7% | 12.1% |
| Operating margin | β9,661.0% | β7,008.9% | β485.4% | β424.2% | β154.6% | β129.5% |
| EBITDA margin | β9,311.0% | β6,901.7% | β431.9% | β376.6% | β105.1% | β81.5% |
| Net margin | β10,254.9% | β8,792.0% | β570.4% | β450.0% | β314.4% | β195.1% |
| FCF margin | β8,853.7% | β7,801.6% | β538.3% | β709.2% | β287.2% | β86.7% |
| Net interest share of revenue | β636.6% | β1,037.3% | β85.9% | β93.4% | β | β |
| Returns | ||||||
| Return on capital | β | β217.8% | β32.8% | β32.6% | β13.1% | β15.8% |
| Return on capital employed | β117.4% | β35.5% | β37.0% | β33.4% | β15.8% | β15.9% |
| Return on equity | β | β113.2% | β99.6% | β181.6% | β | β |
| Return on assets | β92.4% | β73.3% | β52.6% | β37.6% | β29.6% | β22.5% |
| Return on tangible equity | β | β55.2% | β312.2% | β | β | β |
| Growth | ||||||
| Revenue growth | β | 678.0% | 2,952.4% | 41.5% | 38.4% | 26.8% |
| Share count change | β | 6.5% | β87.3% | 18.5% | 6.8% | 99.2% |
| Financial health | ||||||
| Debt / equity | β | 0.1x | 1.0x | 18.2x | β | β |
| Current ratio | 0.3x | 5.9x | 1.5x | 0.8x | 0.3x | 1.4x |
| Quick ratio | 0.2x | 5.8x | 1.3x | 0.7x | 0.2x | 0.9x |
| Capital allocation | ||||||
| Capex / revenue | 4,173.2% | 4,649.8% | 287.7% | 588.8% | 216.2% | 24.0% |
| Stock comp / revenue | 4,018.3% | 2,804.9% | 201.1% | 59.1% | 8.8% | 10.7% |
| Quality scores | ||||||
| Piotroski F-score | β | 4.0 | 3.0 | 3.0 | 4.0 | 5.0 |
| Altman Z'' | β11.7 | 2.9 | β3.3 | β4.7 | β4.9 | β5.3 |
| Accruals ratio | β50.2% | β47.0% | β29.5% | β27.5% | β22.9% | β15.3% |
Source: SEC EDGAR XBRL filings (CIK 0001840780). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.